GRAIL, LLC (GRAL)
Healthcare
Diagnostics & Research
70.30 $
+2.5%
vs. previous close
Closing price · As of: 3. Aug 2026
GRAIL, LLC (GRAL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -87 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -139 | -158 | -129 | -207 | -172 | -105 | -93 | -95 | -77 | -63 | -64 | -87 | -291 | |
| 39 | 40 | 40 | 40 | 39 | 39 | 39 | 39 | 39 | 39 | -117 | 39 | -0.5 | |
| 26 | 25 | 25 | 29 | 26 | 17 | 14 | 16 | 14 | 14 | -45 | 17 | 0.6 | |
| 7.0 | 6.6 | 9.0 | -9.8 | -9.0 | 11 | -16 | 1.5 | -0.8 | 6.8 | -7.5 | -8.1 | -9.7 | |
| 2.9 | 3.1 | 3.9 | 2.5 | 1.4 | 1.0 | 0.3 | 0.1 | 0.4 | 0.4 | 0.8 | 0.5 | 2.1 | |
| -2.9 | -3.1 | -3.9 | -2.5 | -1.4 | -1.0 | -546 | 15 | 70 | 67 | -237 | -93 | -193 | |
| -0.1 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | |
| 195 | 74 | 86 | 312 | 932 | 0.0 | 0.0 | 0.0 | 0.0 | 423 | 423 | – | – | |
| 53 | -87 | -47 | 102 | 759 | -105 | -640 | -80 | -6.5 | 3.1 | 123 | -180 | -61 | |
| -142 | -161 | -133 | -210 | -173 | -106 | -94 | -95 | -77 | -64 | -63 | -87 | -291 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.